SCHEMBL20305366

SCHEMBL20305366

CNC(=O)c1oc2cccc(OC)c2c1C

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 2/20 0.71
MKNK2 Q9HBH9 1/20 0.50
GPR55 Q9Y2T6 1/20 0.50
MMP2 P08253 1/20 0.49
MMP13 P45452 1/20 0.49
HSD17B10 Q99714 5/20 0.48
KDM4E B2RXH2 3/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
MAPT P10636 3/20 0.46
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
HPGD P15428 2/20 0.46
TSHR P16473 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
TP53 P04637 1/20 0.46
NQO1 P15559 1/20 0.46
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
NMT2 O60551 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16698199 0.83 EDNRA (0.68) EDNRAGPR55MMP2MMP13HSD17B10
SCHEMBL3616780 0.83 EDNRA (1.00) EDNRAGPR55MMP2MMP13HSD17B10
SCHEMBL23532178 0.82 KDM1A (0.52) EDNRAMKNK2NPC1RAB9AMAPT
SCHEMBL23532115 0.80 KDM1A (0.60) EDNRAMKNK2MMP2MMP13NPC1
SCHEMBL22010898 0.79 MMP2 (0.47) EDNRAMKNK2MMP2MMP13NPC1
SCHEMBL3607399 0.78 KDM4E (0.76) EDNRAHSD17B10KDM4ENPC1RAB9A
SCHEMBL3602060 0.77 EDNRA (0.68) EDNRAHSD17B10KDM4ENPC1RAB9A
SCHEMBL18702962 0.77 EDNRA (0.48) EDNRAHSD17B10KDM4ENPC1RAB9A
SCHEMBL5242442 0.73 NQO1 (0.46) EDNRAHSD17B10KDM4EKMT2AMEN1
SCHEMBL4109825 0.73 SMN1; SMN2 (0.62) NPC1RAB9AKMT2ATSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3557998-A1 COMPOUNS, COMPOSITIONS AND METHODS OF USE Aquinnah Pharmaceuticals Inc. (US) 2019-10-30 EP disclosed
WO-2018119395-A1 COMPOUNS, COMPOSITIONS AND METHODS OF USE AQUINNAH PHARMACEUTICALS, INC. (US) 2018-06-28 WO disclosed